CFS Investment Advisory Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
ATO
CGH
CFS Investment Advisory Services's GILD Position: Q2 2026 in Review
CFS Investment Advisory Services reduced its Gilead Sciences (GILD) stake by 4.5% in Q2 2026, selling an estimated $71.8K and leaving 11,660 shares worth $1.53M. The position accounts for 0.1% of the portfolio, ranked #158.
CFS Investment Advisory Services first reported a position in GILD in Q2 2023 and has held it in 10 quarters since. The position peaked at $1.68M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- CFS Investment Advisory Services held 11,660 shares of Gilead Sciences worth $1.53M as of Q2 2026.
- CFS Investment Advisory Services sold 545 Gilead Sciences shares in Q2 2026, an estimated $71.8K.
- Gilead Sciences made up 0.1% of CFS Investment Advisory Services's portfolio in Q2 2026, its #158 holding.
- CFS Investment Advisory Services first reported a position in Gilead Sciences in Q2 2023 and has held it in 10 quarters since.
- CFS Investment Advisory Services's Gilead Sciences position peaked at $1.68M in Q1 2026.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on CFS Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.